| scholarly article | Q13442814 |
| P50 | author | Jeffrey R Curtis | Q87706464 |
| P2093 | author name string | Kevin L Winthrop | |
| Lang Chen | |||
| Fenglong Xie | |||
| Huifeng Yun | |||
| Benjamin Chan | |||
| Maria I Danila | |||
| Ben Ehst | |||
| P2860 | cites work | Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative | Q26801221 |
| A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 | ||
| Validating administrative data in stroke research | Q30736500 | ||
| Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data | Q31135274 | ||
| Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses | Q33767803 | ||
| Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems | Q34019930 | ||
| Stroke: who's counting what? | Q34273915 | ||
| Validation of acute myocardial infarction in the Food and Drug Administration's Mini-Sentinel program | Q34320788 | ||
| Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis | Q34348857 | ||
| Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. | Q34785993 | ||
| Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review | Q34812877 | ||
| Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records | Q35816364 | ||
| Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis | Q36030664 | ||
| Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. | Q36101689 | ||
| National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. | Q37027264 | ||
| AJC editor's consensus: psoriasis and coronary artery disease. | Q37343670 | ||
| Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions | Q37743164 | ||
| The association between psoriasis and dyslipidaemia: a systematic review | Q38056160 | ||
| From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies | Q38159088 | ||
| Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group | Q39605645 | ||
| Psoriasis causes as much disability as other major medical diseases | Q41686702 | ||
| The risk of mortality in patients with psoriasis: results from a population-based study | Q43414443 | ||
| Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study | Q43578147 | ||
| Psoriasis and cardiovascular screening rates in the United States. | Q43753062 | ||
| Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study | Q44398860 | ||
| Risk factors for cardiovascular disease in psoriasis: relation to inflammation assessed by the severity and duration of illness | Q44524215 | ||
| Methotrexate reduces the occurrence of cerebrovascular events among Taiwanese psoriatic patients: a nationwide population-based study. | Q44541335 | ||
| Are patients with psoriasis being screened for cardiovascular risk factors? A study of screening practices and awareness among primary care physicians and cardiologists | Q44577764 | ||
| Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients | Q47743748 | ||
| Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone | Q48522893 | ||
| Delivery of preventive services to older adults by primary care physicians | Q48947785 | ||
| Rare outcomes, common treatments: analytic strategies using propensity scores. | Q52030565 | ||
| Psoriasis | Q56115291 | ||
| Risk of Myocardial Infarction in Patients With Psoriasis | Q60711909 | ||
| Impact of obesity and smoking on psoriasis presentation and management | Q81645553 | ||
| Anti-TNF-α therapy improves insulin sensitivity in non-diabetic patients with psoriasis: a 6-month prospective study | Q85888806 | ||
| Increased burden of inflammation over time is associated with the extent of atherosclerotic plaques in patients with psoriatic arthritis | Q87874278 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 128-137 | |
| P577 | publication date | 2016-01-01 | |
| P1476 | title | Risk of Cardiovascular Outcomes among Psoriasis Patients Treated with Biologics and Other Systemic Agents | |
| P478 | volume | 1 |
| Q92244417 | Pediatric psoriatic arthritis: a population-based cohort study of risk factors for onset and subsequent risk of inflammatory comorbidities | cites work | P2860 |
Search more.